We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma.
- Authors
Daud, A I; Xu, C; Hwu, W-J; Urbas, P; Andrews, S; Papadopoulos, N E; Floren, L C; Yver, A; Deconti, R C; Sondak, V K
- Abstract
High-dose pegylated interferon α-2b (peginterferon α-2b) significantly decreased disease recurrence in patients with resected stage III melanoma in a clinical study. We investigated the pharmacokinetics (PK) and safety of high-dose peginterferon α-2b in patients with high-risk melanoma.
- Publication
Cancer chemotherapy and pharmacology, 2011, Vol 67, Issue 3, p657
- ISSN
1432-0843
- Publication type
Journal Article
- DOI
10.1007/s00280-010-1326-9